Directorate Change
RNS Number : 5527V
Angelfish Investments PLC
10 August 2020
 

10 August 2020

 

Angelfish Investments Plc

("Angelfish" or "the Company")

 

Directorate Change

 

Following the announcement on 18 June 2020, the Directors are pleased to announce that Mr Brian Jones has been appointed as Non-Executive Chairman with immediate effect. 

 

Since July 2018, Brian has been Group CEO of Partnership of East London Cooperatives, a not-for-profit Social Enterprise providing NHS 111, primary care out of hours services and urgent care centre services to over 1.1 million patients in the areas of Barking & Dagenham, Redbridge, Havering and Waltham Forest. Prior to this role, he held senior financial and management roles in the NHS and the education sector with a focus on restructuring, change management and stakeholder engagement.

 

In 2016, Brian joined the Authority Committee of the Health Products Regulatory Authority, Ireland, whose role is to protect and enhance public and animal health by regulating medicines, medical devices and other health products, an appointment by the Minister of Health for an initial five year term. Brian has a BSc in Facilities Planning and Management and an MBA and he is also a trustee of British Blind Sports.

 

Current directorships and appointments:

·      Ecogreen Technologies Limited

·      Urgent Health UK Limited

·      Forest Community Health Limited

·      British Blind Sport

·      Fortisalis Healthcare Limited

·      Health Products Regulatory Authority (Ireland

 

Past directorships and appointments:

·      NHS Norwich Clinical Commissioning Group

 

Richard Walker, Director of Angelfish, commented:

"The Board are delighted that Brian has agreed to join Angelfish as we look to begin a new chapter for the Company. Brian brings a wealth of knowledge and experience which will be invaluable as we look to identify new opportunities in the health sector."

 

There are no further details required to be disclosed pursuant to Appendix 1, Table A, paragraph 5.1.2. of the AQSE Growth Market Rules for Issuers.

 

This announcement contains information which, prior to its disclosure, was inside information for the purposes of Article 7 of EU Regulation 596/2014.  

 

 

--ENDS--

Enquiries:

 

Angelfish Investments Plc

Richard Walker

 

 

+44 (0)7772 013116

 

AQSE Corporate Adviser

Novum Securities Limited

David Coffman / Daphne Zhang

 

 

 

+44 (0)207 399 9400

 

 

 

 

About Angelfish Investments plc

 

The Company's Ordinary Shares and Preference Shares are admitted to trading on the AQSE Growth Market in London. The Company has the trading symbol ANGP for its Ordinary Shares and the trading symbol ANGS for its Preference Shares.


This information is provided by RNS, the news service of the . RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NEXBUGDIGDGDGGR ]]>